sector medic suppli devic
momentum rais pt
messag report solid result wednesday would
look impress stronger fx headwind street
model expect currenc drive estim modestli lower well
underneath fx nois howev believ fundament remain robust
organ revenu growth came second straight quarter management
indic growth could possibl next year outlook view
achiev rais pt reiter buy rate
anoth quarter broad-bas top-lin strength abbott sale rose
organ basi upsid medic devic nutrit off-set modest miss
diagnost pronounc weak establish pharma would chalk
epd miss primarili currenc estim increment fx headwind account
shortfal underli growth also slow expect
given challeng yoy comp elsewher pediatr nutrit continu enjoy strong
momentum ou follow transit new reg china cc upsid
help off-set soft adult side abbott wind non-cor product
line meanwhil diagnost segment best quarter sinc driven strength
lab alin roll-out pick steam abbott estim eu
system placement date competit win view posit lead
indic ahead broader launch
medic devic side libr continu shine third quarter revenu
rose yoy top consensu remark achiev product
gener sale estim revenu
top ramp ceo mile white note call abbott
invest aggress extra capac facilit growth product pipelin
manag give detail expect time fda approv
libr continu believ launch product along pediatr
label expans could come soon
elsewher devic see plenti reason think abbott current
momentum could actual improv otherwis strong
perform neuromodul heart failur disappoint weak
neuro hangov execut issu first crop manag
believ take least one quarter busi begin turn corner
mr white note expect return doubl digit growth next year meanwhil
heart failur shortfal driven center draw remain heartmat
inventori ahead heartmat dt indic abbott expect immin
approv hand forecast return high-singl digit growth elsewher
abbott remain track receiv crt-p mri label yearend help
build improv perform final continu see mitraclip
potenti sourc upsid back coapt data abbott track
file label expans cover fmr patient next week take
togeth estim underli growth cardio neuro segment could
acceler next year help abbott sustain current top
line momentum even comp toughen libr pediatr nutrit
reiter buy model call abbott report ep
total revenu organ lower ep forecast
take account increas fx headwind expect
like modest upward pressur abbott tax rate treasuri final new reg
relat corpor tax reform legisl longer term continu see
sustain grower top bottom line respect outlook
believ support premium valuat rel lc med-tech peer
page analyst certif import disclosur
abbott one largest healthcar compani world boast top line
lead franchis across medic devic diagnost nutrit establish
pharmaceut segment path get point long wind one
abbott reshuffl portfolio sever time past two decad recent
acquisit st jude medic aler dust settl
deal abbott emerg premium grower within large-cap med-tech group
model call compani deliv top bottom line gain
respect compar averag peer yet
stock trade today modest premium group ntm ep vs
provid opportun rel multipl expans visibl sustain
growth trajectori improv
abbott share current trade ntm ep estim ntm
ebitda modestli large-cap med-tech averag
respect believ abbott above-averag growth profil peg
top bottom line respect vs group averag
warrant premium valuat rais price target previous
base previous multipl forward ntm ep estim
signific upsid potenti target current level assign abbott buy
downsid risk rate price target includ integr challeng relat
st jude aler acquisit pipelin setback and/or neg clinic result
impact abbott competit adopt key new product libr alin
etc fall short street expect
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
point
compani report guggenheim secur llc estim
page analyst certif import disclosur
